EBITDA: Income before interest, taxes, depreciation and amortization.
MARKER THERAPEUTICS, INC. (MRKR) had EBITDA of $-11.12M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$6.59M |
|
$-10.73M |
|
-- |
|
$6.59M |
|
$17.71M |
|
$-11.12M |
|
$0.44M |
|
$-10.68M |
|
$-10.68M |
|
$-10.73M |
|
$-10.73M |
|
$-10.73M |
|
$-10.73M |
|
$-11.12M |
|
|
EBITDA |
$-11.12M |
8.98M |
|
8.98M |
|
$-1.19 |
|
$-1.19 |
|
| Balance Sheet Financials | |
$22.02M |
|
-- |
|
-- |
|
$22.02M |
|
$3.46M |
|
-- |
|
-- |
|
$3.46M |
|
$18.56M |
|
$18.56M |
|
$18.56M |
|
10.70M |
|
| Cash Flow Statement Financials | |
$-10.91M |
|
-- |
|
$14.99M |
|
$15.11M |
|
$19.19M |
|
$4.08M |
|
$0.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-168.69% |
|
-168.69% |
|
-168.69% |
|
-162.06% |
|
-162.82% |
|
$-10.91M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
-- |
|
2.81 |
|
129.96 |
|
-57.82% |
|
-57.82% |
|
-48.73% |
|
-57.82% |
|
$1.73 |
|
$-1.21 |
|
$-1.21 |
|